Conmed Corp
CNMD40.770USD
+0.600+1.49%
종가 12/26, 16:00（ET）시세는 15분 지연됩니다
1.26B시가총액
19.71P/E TTM
자세한 내용은 Conmed Corp 회사
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Conmed Corp 정보
종목 코드 CNMD
회사 이름Conmed Corp
상장일Jul 23, 1987
CEOBeyer (Patrick J)
직원 수3900
유형Ordinary Share
회계 연도 종료Jul 23
주소11311 Concept Boulevard
도시LARGO
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호33773
전화17272142974
웹사이트https://www.conmed.com/
종목 코드 CNMD
상장일Jul 23, 1987
CEOBeyer (Patrick J)
Conmed Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
Ms. Hollie Foust
Ms. Hollie Foust
Executive Vice President, General Counsel and Corporate Secretary
Executive Vice President, General Counsel and Corporate Secretary
2.89K
--
Mr. Brent Lalomia
Mr. Brent Lalomia
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations
1.13K
+18.20%
Mr. Kim Kelderman
Mr. Kim Kelderman
Independent Director
Independent Director
--
--
Mr. Richard Glaze
Mr. Richard Glaze
Chief Information Officer
Chief Information Officer
--
-100.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. David M. Bronson
Mr. David M. Bronson
Independent Director
Independent Director
17.24K
+2.86%
Mr. Stephan Epinette
Mr. Stephan Epinette
Vice President and General Manager, International
Vice President and General Manager, International
15.51K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
10.81K
--
Mr. Brian P. Concannon
Mr. Brian P. Concannon
Independent Director
Independent Director
10.12K
+4.97%
Ms. Barbara J. Schwarzentraub
Ms. Barbara J. Schwarzentraub
Independent Director
Independent Director
5.79K
+9.03%
Mr. Peter K Shagory
Mr. Peter K Shagory
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
3.90K
+5.01%
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
지역별USD
이름
수익
비율
United States
190.61M
55.68%
Europe & Middle East & Africa
63.92M
18.67%
Asia Pacific
42.07M
12.29%
Americas (excluding the United States)
31.88M
9.31%
사업별
지역별
사업별USD
이름
수익
비율
General Surgery
201.61M
58.89%
Orthopedic Surgery
140.73M
41.11%
주식 보유 통계
마지막 업데이트: Sun, Nov 30
마지막 업데이트: Sun, Nov 30
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
기타
55.53%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
13.90%
The Vanguard Group, Inc.
11.63%
EARNEST Partners, LLC
9.04%
Fuller & Thaler Asset Management Inc.
5.60%
Westwood Management Corp. (Texas)
4.29%
기타
55.53%
주주 유형
주주
비율
Investment Advisor
55.01%
Investment Advisor/Hedge Fund
46.65%
Hedge Fund
7.01%
Research Firm
2.89%
Pension Fund
1.93%
Bank and Trust
0.68%
Individual Investor
0.59%
Sovereign Wealth Fund
0.06%
Insurance Company
0.04%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
638
36.30M
136.51%
+226.00
2025Q3
655
36.31M
137.32%
-1.03M
2025Q2
649
37.27M
138.33%
-832.15K
2025Q1
642
38.16M
137.89%
-4.49M
2024Q4
628
38.56M
133.23%
+1.56M
2024Q3
620
37.00M
134.64%
-1.79M
2024Q2
640
38.79M
129.72%
+1.14M
2024Q1
637
37.49M
133.32%
-3.56M
2023Q4
623
39.15M
131.18%
+747.69K
2023Q3
604
38.42M
132.14%
+127.38K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
4.43M
14.3%
-133.34K
-2.92%
Jun 30, 2025
The Vanguard Group, Inc.
3.54M
11.44%
+42.41K
+1.21%
Jun 30, 2025
EARNEST Partners, LLC
2.83M
9.14%
+30.22K
+1.08%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.74M
5.62%
+566.60K
+48.26%
Jun 30, 2025
Westwood Management Corp. (Texas)
1.24M
4%
-484.00
-0.04%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.08M
3.5%
+184.21K
+20.50%
Jun 30, 2025
State Street Investment Management (US)
1.29M
4.18%
-8.83K
-0.68%
Jun 30, 2025
Managed Account Advisors LLC
1.38M
4.47%
+103.77K
+8.11%
Jun 30, 2025
Silvercrest Asset Management Group LLC
851.95K
2.75%
-183.66K
-17.73%
Jun 30, 2025
Capital Research Global Investors
1.68M
5.41%
+2.76K
+0.16%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
State Street SPDR S&P Health Care Equipment ETF
1.48%
ROBO Global Healthcare Technology & Innovation ETF
1.05%
Invesco S&P SmallCap Health Care ETF
0.83%
Harbor Human Capital Factor US Small Cap ETF
0.56%
First Trust Small Cap Value AlphaDEX Fund
0.49%
VictoryShares Small Cap Free Cash Flow ETF
0.36%
WisdomTree US SmallCap Quality Dividend Growth
0.24%
First Trust Small Cap Core Alphadex Fund
0.24%
Lattice Hartford Multifactor Small Cap ETF
0.23%
Franklin US Small Cap Multifactor Index ETF
0.2%
더 보기
State Street SPDR S&P Health Care Equipment ETF
비율1.48%
ROBO Global Healthcare Technology & Innovation ETF
비율1.05%
Invesco S&P SmallCap Health Care ETF
비율0.83%
Harbor Human Capital Factor US Small Cap ETF
비율0.56%
First Trust Small Cap Value AlphaDEX Fund
비율0.49%
VictoryShares Small Cap Free Cash Flow ETF
비율0.36%
WisdomTree US SmallCap Quality Dividend Growth
비율0.24%
First Trust Small Cap Core Alphadex Fund
비율0.24%
Lattice Hartford Multifactor Small Cap ETF
비율0.23%
Franklin US Small Cap Multifactor Index ETF
비율0.2%
주식 배당금
지난 5년 동안 총
119.19M
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Aug 08, 2025
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 03, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 03, 2025
Sep 15, 2025
May 21, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 03, 2025 going ex on Jun 13, 2025
Jun 13, 2025
Jul 03, 2025
Jun 13, 2025
Feb 25, 2025
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 04, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 04, 2025
Mar 14, 2025
Dec 10, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 03, 2025 going ex on Dec 20, 2024
Dec 20, 2024
Jan 03, 2025
Dec 20, 2024
Aug 09, 2024
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 04, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 04, 2024
Sep 16, 2024
May 22, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 05, 2024
Jun 14, 2024
Feb 26, 2024
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Dec 05, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jan 05, 2024 going ex on Dec 15, 2023
Dec 18, 2023
Jan 05, 2024
Dec 15, 2023
Aug 10, 2023
CNMD.NB Final Cash Dividend of gross USD 0.2 paid on Oct 05, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 05, 2023
Sep 14, 2023
May 24, 2023
CNMD.NB Interim Cash Dividend of gross USD 0.2 paid on Jul 05, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 05, 2023
Jun 14, 2023
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
자주 묻는 질문
Conmed Corp의 상위 5대 주주는 누구인가요?
Conmed Corp의 상위 5대 주주는 다음과 같습니다:
BlackRock Institutional Trust Company, N.A.는 4.43M주의 주식을 보유하고 있으며, 전체 주식의 14.30%를 차지합니다.
The Vanguard Group, Inc.는 3.54M주의 주식을 보유하고 있으며, 전체 주식의 11.44%를 차지합니다.
EARNEST Partners, LLC는 2.83M주의 주식을 보유하고 있으며, 전체 주식의 9.14%를 차지합니다.
Fuller & Thaler Asset Management Inc.는 1.74M주의 주식을 보유하고 있으며, 전체 주식의 5.62%를 차지합니다.
Westwood Management Corp. (Texas)는 1.24M주의 주식을 보유하고 있으며, 전체 주식의 4.00%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 4.43M주의 주식을 보유하고 있으며, 전체 주식의 14.30%를 차지합니다.
The Vanguard Group, Inc.는 3.54M주의 주식을 보유하고 있으며, 전체 주식의 11.44%를 차지합니다.
EARNEST Partners, LLC는 2.83M주의 주식을 보유하고 있으며, 전체 주식의 9.14%를 차지합니다.
Fuller & Thaler Asset Management Inc.는 1.74M주의 주식을 보유하고 있으며, 전체 주식의 5.62%를 차지합니다.
Westwood Management Corp. (Texas)는 1.24M주의 주식을 보유하고 있으며, 전체 주식의 4.00%를 차지합니다.
Conmed Corp의 상위 3대 주주 유형은 무엇인가요?
Conmed Corp의 주요 주주 유형 상위 3가지는
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
EARNEST Partners, LLC입니다.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
EARNEST Partners, LLC입니다.
Conmed Corp(CNMD)의 주식을 보유한 기관은 몇 개입니까?
2025Q4 기준으로, Conmed Corp의 주식을 보유한 기관은 총 638곳이며, 이들이 보유한 주식의 총 가치는 약 36.30M로 전체 발행 주식의 136.51%를 차지합니다. 이는 2025Q3 대비 -0.81% 증가한 수치입니다.
Conmed Corp의 최대 수익원은 무엇인가요?
FY2025Q2 기준, Conmed Corp의 General Surgery 부문이 가장 높은 매출을 기록했으며, 금액은 201.61M로 전체 매출의 58.89%를 차지했습니다.
